Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 2013

View Archived Issues

Noninvasive electroencephalograph for functional brain analysis in monkeys

Preclinical evaluation of a mixed-mirror image DNA/RNA aptamer to regulate glucose tolerance

Characterization of an in vitro 3D culture model of human brain development

Data published from phase II evaluations of a troponin activator in patients with ALS

Reductions in rheumatic pain seen with willow bark extract STW-33-1

University of Pennsylvania discloses new ICOS-based CAR inhibitors for cancer

Italian researchers patent novel oligonucleotides for cancer

Researchers at Janssen Pharmaceutica prepare novel endothelial lipase inhibitors

Canadian group patents novel polypeptides binding to prothrombin

CP-9531 demonstrates efficacy for multiple sclerosis

PaxVax begins phase III trial challenge studies for single-dose oral cholera vaccine

Cellular Biomedicine reports phase I/IIa cell therapy trial data for knee osteoarthritis

Exon-skipping compound PRO-053 begins phase I/II trial for Duchenne muscular dystrophy

Sobi acquires full rights to Kineret, additional data for Kepivance

FDA approves Abraxane for advanced pancreatic cancer

Toa Eiyo and Astellas Pharma set to launch Bisono Tape in Japan

Genkyotex obtains IND approval for phase II study of GKT-137831

Diurnal completes pharmacokinetic portion of CATCH trial in congenital adrenal hyperplasia

QRxPharma to discuss MoxDuo NDA with FDA prior to refiling

BIOD-123 demonstrates glycemic control comparable to Humalog in phase II study

FDA grants QIDP designation to Cempra's solithromycin

Baxter completes acquisition of Gambro

GenVec withdraws plan of dissolution

Civitas Therapeutics begins phase IIb study of inhaled levodopa

Cempra's solithromycin well tolerated in patients with chronic liver disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...